CENTRAL LABORATORIES WHITE PAPERS & ARTICLES

CENTRAL LABORATORIES APPLICATIONS & STUDIES

CENTRAL LABORATORIES PRODUCTS & SERVICES

Ergomed’s Meticulous Risk-Based Quality Management Approach

As a pioneer in providing comprehensive support for your clinical research, Ergomed champions an innovative Risk-Based Quality Management (RBQM) approach. This forward-thinking strategy ensures the highest patient safety standards, regulatory compliance, and data reliability. Ergomed’s proactive approach to managing clinical trials tackles clinical research complexity head-on.

Streamline clinical trial data capture through eSource workflows that support both Direct Data Capture and automated EHR-to-EDC data transfer across Paradigm Health’s research-ready provider network.

Research teams can capture study data within the EHR or through a standalone application, enabling consistent workflows across sites while reducing manual transcription. Sponsors gain faster access to cleaner trial data with fewer queries and more efficient monitoring.

More than just an electronic data collection tool, our robust clinical data management system combines an intuitive user interface, seamless online and offline data capture capabilities, and comprehensive data management for clinical trials in a single solution.

Bioforum’s clinical research experts have developed an intuitive and easy-to-navigate analytics and visualization platform.
BioGRID brings clinical trial data together in a clear, focused manner to drive smart decision-making processes.

Experience higher data quality, retention and participant compliance by providing a truly engaging experience from data submission to reminders, appointment management, telemedicine and more -- from the phone, tablet, or desktop.

Technology solutions for life sciences that get products to market quickly and efficiently.

Intelligently manage the entire file lifecycle, from creation and active usage to archival and removal.

The Australian Advantage is about saving time and minimizing costs while generating internationally accepted data in preparation for the next Phase.